Market Snapshot: Global Insulin Pumps Market Eyes Nearly 10% Growth By 2022
Executive Summary
The worldwide insulin pumps market is expected to reach more than $4.5bn by 2022, a CAGR of nearly 10%. This market is largely driven by the rising prevalence of diabetes and the need to control spiraling health-care costs associated with diabetes-related complications. While Medtronic's MiniMed 670G dominates the market, Informa's MedDeviceTracker expects Medtronic will see rising competition from innovative start-ups.
You may also be interested in...
Market Intel: CGM Market Competition And Device Interoperability Were Hot Topics At ADA2019
Interoperability and the rising use of continuous glucose monitoring is fueling competition among diabetes device-makers and dominated the conversation at the recent annual ADA meeting.
ADA Exec Chat: Hiten Chawla, Medtronic's VP Of Global Marketing Discusses Diabetes Business Plans
At this year's American Diabetes Association (ADA) meeting in San Francisco, medtech giant Medtronic made several key announcements including a collaboration with Tidepool Loop, the start of a new patient trial to develop its next-generation hybrid closed-loop system and another trial to improve its sensor technology. Medtech Insight met up with Hiten Chawla, Medtronic's VP of global marketing for its diabetes business, to learn more about these plans.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.